Andrew Geall
Company: Replicate Bioscience
Job title: Co-founder & Chief Development Officer
Seminars:
Chair’s Closing Remarks 4:00 pm
day: Day Two
Panel Discussion: Discussing Emerging LNP Modifications & Polymer-Based RNA Delivery for Next Generation RNA Therapeutics 2:30 pm
Outlining the advantages of different LNP modifications to enhance target specificity of next generation RNA therapeutics Describing the biological mechanism of LNP and polymer-based delivery to increase target specificity Discussing the challenges of maintaining sufficient extrahepatic protein expressionRead more
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Day Two